Market capitalisation, EUR | 219.192,10 Mio. |
EPS, EUR | 1,88 |
P/B ratio | 6,41 |
P/E ratio | 37,64 |
Dividend yield | 1,85% |
Revenue, EUR | 42.374,41 Mio. |
Net income, EUR | 5.508,28 Mio. |
Profit margin | 13,00% |
ETF | Weight | Investment focus | Holdings | TER | Fund size (in m EUR) | Return 1Y | WKN | ISIN |
---|---|---|---|---|---|---|---|---|
Invesco NASDAQ-100 Equal Weight UCITS ETF Acc | 0.99% | Equity Technology Equal Weighted | 101 | 0.20% | - | - | A3EE27 | IE000L2SA8K5 |
First Trust Value Line® Dividend Index UCITS ETF Acc | 0.57% | Equity United States Dividend | 175 | 0.70% | 18 | +7.77% | A2PZMV | IE00BKVKW020 |
WisdomTree Megatrends UCITS ETF USD | 0.06% | Equity World Social/Environmental Innovation | 580 | 0.50% | 11 | - | A3EYCN | IE0000902GT6 |
Invesco EQQQ Nasdaq-100 UCITS ETF Acc | 0.29% | Equity United States Technology | 101 | 0.30% | 1,927 | +36.64% | A2N6RV | IE00BFZXGZ54 |
Invesco Nasdaq-100 ESG UCITS ETF Acc | 0.26% | Equity United States Technology Social/Environmental | 94 | 0.25% | 1,167 | +38.50% | A3CZGT | IE000COQKPO9 |
WisdomTree BioRevolution UCITS ETF USD Acc | 1.02% | Equity World Health Care Social/Environmental Biotech | 88 | 0.45% | 3 | -5.20% | A3CY21 | IE000O8KMPM1 |
iShares Nasdaq 100 UCITS ETF EUR Hedged Acc | 0.28% | Equity United States Technology | 101 | 0.36% | 640 | +34.33% | A2N34W | IE00BYVQ9F29 |
iShares Nasdaq 100 UCITS ETF (DE) | 0.28% | Equity United States Technology | 101 | 0.31% | 3,882 | +36.42% | A0F5UF | DE000A0F5UF5 |
L&G Global Thematic ESG Exclusions UCITS ETF USD Accumulating | 0.47% | Equity World Social/Environmental Innovation | 359 | 0.60% | 4 | +5.41% | A3DHPA | IE000VTOHNZ0 |
Xtrackers Nasdaq 100 UCITS ETF 1C | 0.29% | Equity United States Technology | 101 | 0.20% | 662 | +36.78% | A2QJU3 | IE00BMFKG444 |
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 4.07% | Equity United States Health Care Biotech | 219 | 0.35% | 33 | +6.33% | A2JDYM | IE00BDZVHG35 |
iShares Nasdaq US Biotechnology UCITS ETF | 4.07% | Equity United States Health Care Biotech | 219 | 0.35% | 445 | +6.32% | A2DWAW | IE00BYXG2H39 |
Invesco Nasdaq-100 UCITS ETF EUR Hedged | 0.29% | Equity United States Technology | 101 | 0.35% | 230 | +34.34% | A2DT9V | IE00BYVTMS52 |
Invesco Nasdaq-100 UCITS ETF CHF Hedged | 0.29% | Equity United States Technology | 101 | 0.35% | 251 | +31.85% | A2JAN0 | IE00BYVTMT69 |
Invesco Nasdaq-100 UCITS ETF GBP Hedged | 0.29% | Equity United States Technology | 101 | 0.35% | 255 | +37.63% | A2JNFA | IE00BYVTMW98 |
Deka Nasdaq-100® UCITS ETF | 0.28% | Equity United States Technology | 101 | 0.25% | 39 | - | ETFL62 | DE000ETFL623 |
L&G Pharma Breakthrough UCITS ETF | 2.47% | Equity World Health Care Innovation | 43 | 0.49% | 18 | -15.76% | A2H9XR | IE00BF0H7608 |
Invesco EQQQ Nasdaq-100 UCITS ETF | 0.29% | Equity United States Technology | 101 | 0.30% | 6,240 | +36.66% | 801498 | IE0032077012 |
iShares Nasdaq 100 UCITS ETF (Acc) | 0.28% | Equity United States Technology | 101 | 0.33% | 12,513 | +36.61% | A0YEDL | IE00B53SZB19 |
YTD | +22.88% |
1 month | +11.69% |
3 months | +22.90% |
6 months | +22.94% |
1 year | +3.67% |
3 years | +39.02% |
5 years | - |
Since inception (MAX) | +53.74% |
2023 | -9.11% |
2022 | +17.20% |
2021 | - |
2020 | - |
Volatility 1 year | 22.20% |
Volatility 3 years | 23.79% |
Volatility 5 years | - |
Return per risk 1 year | 0.17 |
Return per risk 3 years | 0.49 |
Return per risk 5 years | - |
Maximum drawdown 1 year | -20.20% |
Maximum drawdown 3 years | -21.12% |
Maximum drawdown 5 years | - |
Maximum drawdown since inception | -21.12% |